Keywords: Merck KGaA, Serono, China, R&D, Investment

Merck KGaA to boost R&D presence in China with $223 million investment

Article | 23 November 2009

Print This

German drug major Merck KGaA is the latest in a string of multinationals to view China as a good base ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in